Patents Assigned to RETINAGENIX THERAPEUTICS, INC.
  • Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency
    Patent number: 10828267
    Abstract: Disclosed herein are therapeutic regimens for improving visual function in Retinitis Pigmentosa and other visual disorders associated with an endogenous retinoid deficiency in a subject by administering a therapeutically effective amount of a synthetic retinal derivative, for example a 9- or 11-cis retinyl ester, according to the therapeutic regimen which leads to local recovery of visual functions such as visual fields, visual acuity and retinal sensitivity, among others.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 10, 2020
    Assignee: RETINAGENIX THERAPEUTICS, INC.
    Inventor: Suzanne Cadden
  • Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
    Patent number: 10736865
    Abstract: Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: August 11, 2020
    Assignee: RETINAGENIX THERAPEUTICS, INC.
    Inventor: Ronald Erwin Boch